Cargando…
The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells
Rhabdomyosarcoma (RMS), the most common cancer of connective tissues in pediatrics, is often resistant to conventional therapies. One underlying mechanism of this resistance is the overexpression of Inhibitor of Apoptosis (IAP) proteins, leading to a dysfunctional cell death program within tumor cel...
Autores principales: | Fischer, Kyra, Tognarelli, Sara, Roesler, Stefanie, Boedicker, Cathinka, Schubert, Ralf, Steinle, Alexander, Klingebiel, Thomas, Bader, Peter, Fulda, Simone, Ullrich, Evelyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339542/ https://www.ncbi.nlm.nih.gov/pubmed/28326081 http://dx.doi.org/10.3389/fimmu.2017.00202 |
Ejemplares similares
-
Characterization of BV6-Induced Sensitization to the NK Cell Killing of Pediatric Rhabdomyosarcoma Spheroids
por: Särchen, Vinzenz, et al.
Publicado: (2023) -
Selective BH3 mimetics synergize with BET inhibition to induce mitochondrial apoptosis in rhabdomyosarcoma cells
por: Erdogdu, Ufuk, et al.
Publicado: (2021) -
SMAC Mimetic BV6 Enables Sensitization of Resistant Tumor Cells but also Affects Cytokine-Induced Killer (CIK) Cells: A Potential Challenge for Combination Therapy
por: Rettinger, Eva, et al.
Publicado: (2014) -
Redox regulation of Smac mimetic-induced cell death
por: Fulda, Simone
Publicado: (2015) -
Regulation of cancer stem-like cell differentiation by Smac mimetics
por: Fulda, Simone
Publicado: (2014)